Do Elderly Lung Cancer Patients Aged ≥75 Years Benefit from Immune Checkpoint Inhibitors? by Nagio Takigawa, Nobuaki Ochi, Nozomu Nakagawa, Yasunari Nagasaki, Masataka Taoka, Naruhiko Ichiyama, Ayaka Mimura, Hidekazu Nakanishi, Hiroyuki Kohara, Hiromichi Yamane

Get full text

Ceftriaxone-associated pancreatitis captured on serial computed tomography scans by Nozomu Nakagawa, MD, Nobuaki Ochi, MD, PhD, Hiromichi Yamane, MD, PhD, Yoshihiro Honda, MD, PhD, Yasunari Nagasaki, MD, Noriyo Urata, MD, Hidekazu Nakanishi, MD, PhD, Hirofumi Kawamoto, MD, PhD, Nagio Takigawa, MD, PhD

Get full text